# Response Biomedical Corp.

- Location (FDA's records): Burnaby, British Columbia, CA
- FDA decisions: 7 (2001–2009): 7 510(k) clearances
- Product codes: PSZ (2), NBC (1), DDR (1), JHX (1), GQG (1), MMI (1)
- Predicates its devices cite: 12 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Roche Diagnostics Corp.: 3 (https://510kreport.com/company/roche-diagnostics)
- Biosite Incorporated: 3 (https://510kreport.com/company/biosite)
- Dade Chemistry Systems, Inc.: 2 (https://510kreport.com/company/dade-chemistry-systems)
- Nanogen, Inc.: 1 (https://510kreport.com/company/nanogen)
- Beckman Coulter, Inc.: 1 (https://510kreport.com/company/beckman-coulter)
- Binax, Inc.: 1 (https://510kreport.com/company/binax)

## Its most-cited devices
- K071591: Ramp Influenza  a/B Assay (2008), cited by 1

## Recent decisions
- K093116: Modification to: Ramp Influenza a/B Assay (Oct 21, 2009)
- K091235: Ramp RSV Assay (Jul 24, 2009)
- K063662: Ramp NT-Probnp Assay (Jul 21, 2008)
- K071591: Ramp Influenza  a/B Assay (Apr 16, 2008)
- K033747: Ramp CK-MB Assay (May 17, 2004)
- K033745: Ramp Troponin I Assay (May 17, 2004)
- K012040: Ramp Myoglobin Assay (Dec 18, 2001)

Source page: https://510kreport.com/company/response-biomedical